联合检测肿瘤标志物在原发性肝癌中诊断价值的研究

The research of diagnostic value of combined detection of tumor markers in primary hepatocellular carcinoma

原发性肝癌是一种常见、多发、死亡率高的恶性肿瘤之一。近年来,其发病率仍较高。由于原发性肝癌发病隐匿,亚临床肝癌本身又无症状和体征,临床诊断时多属中晚期,且治愈率低,复发率高,故早期诊断是提高患者生存率的最佳途径。应用多种血清肿瘤标志物联合检测能提高原发性肝癌诊断的准确性,并降低原发性肝癌诊断的漏诊率,同时也有助于临床治疗中的疗效评价及预后判断。

Primary hepatocellular carcinoma is one of the common,multiple,high mortality rate of malignant tumors.ln recent years,its morbidity is still high.Because the primary hepatocellular carcinoma having insidious onset,subclinical hepatocellular carcinoma itself having no symptoms and signs,then when it was diagnosed and it belonged to more in- termediate and advanced stage,and its cure rate is low,the recurrence rate is high,so early diagnosis is the best way to improve the survival rate of patients.The combined detection of multiple serum tumor markers can improve the accura- cy of diagnosis of primary hepatocellular carcinoma,reduce the rate of missed diagnosis,simultaneously also is helpful to evaluation of curative effect and prognosis diagnosis in the clinical treatment.